Merck Sharp & Dohme Corp. and plaintiffs’ counsel in four Canadian Vioxx class actions announced Jan. 19 that they have agreed to settle the litigation for up to $ 36.3 million (Mignacca, et al. v. Merck Frosst Canada Ltd, et al., No. 04-CV-045435CP, Ontario Super. Ct. of Justice; Pelletier v. Merck & Co. Inc., et [...]